- Investing Ideas
- South Korean Pharmaceuticals & Biotech Mid-Large Cap Stocks
South Korean Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
31
Mid-Large Cap Stocks
31 companies
PharmaResearch
Market Cap: ₩4.4t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩425,500.00
7D
7.9%
1Y
-37.8%
Yuhan
Market Cap: ₩6.2t
Operates as a pharmaceutical company in South Korea and internationally.
A000100
₩82,500.00
7D
6.0%
1Y
-27.9%
Seegene
Market Cap: ₩1.5t
Manufactures and sells molecular diagnostics products worldwide.
A096530
₩31,900.00
7D
11.1%
1Y
14.3%
Samsung BiologicsLtd
Market Cap: ₩72.4t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,564,000.00
7D
3.3%
1Y
-1.5%
GC Biopharma
Market Cap: ₩1.5t
A biopharmaceutical company, develops and sells pharmaceutical drugs in South Korea and internationally.
A006280
₩129,500.00
7D
2.4%
1Y
-3.8%
D&D Pharmatech
Market Cap: ₩2.8t
Engages in the research and development and manufacturing of pharmaceuticals in South Korea.
A347850
₩61,700.00
7D
10.8%
1Y
70.2%
L&C BIOLTD
Market Cap: ₩1.5t
Operates as a research and development company in tissue regeneration medicine.
A290650
₩54,700.00
7D
-14.3%
1Y
74.2%
Samsung Epis Holdings
Market Cap: ₩10.0t
A biotechnology company, manage the portfolio of biopharmaceutical products.
A0126Z0
₩403,000.00
7D
0.2%
1Y
n/a
SK bioscienceLtd
Market Cap: ₩2.9t
Engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally.
A302440
₩36,850.00
7D
2.6%
1Y
-21.0%
Hanall Biopharma
Market Cap: ₩3.1t
A pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.
A009420
₩60,400.00
7D
8.6%
1Y
106.5%
NatureCellLtd
Market Cap: ₩1.5t
Engages in manufacturing and selling of canned and health functional food products, beverages, stem cell, and cosmetics in South Korea.
A007390
₩23,600.00
7D
8.0%
1Y
12.1%
Hanmi Pharm
Market Cap: ₩5.1t
A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.
A128940
₩398,500.00
7D
1.9%
1Y
42.6%
Peptron
Market Cap: ₩4.6t
Engages in the development of peptide-based medicines.
A087010
₩196,700.00
7D
10.5%
1Y
-44.4%
Oscotec
Market Cap: ₩1.5t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩38,300.00
7D
8.3%
1Y
11.0%
SK Biopharmaceuticals
Market Cap: ₩6.9t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩87,600.00
7D
4.9%
1Y
-12.9%
Mezzion PharmaLtd
Market Cap: ₩2.1t
Develops, manufactures, and sells pharmaceutical products in South Korea.
A140410
₩67,800.00
7D
22.2%
1Y
81.3%
Hugel
Market Cap: ₩2.8t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩262,500.00
7D
-5.9%
1Y
-17.2%
Celltrion Pharm
Market Cap: ₩2.0t
A pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea.
A068760
₩44,650.00
7D
2.8%
1Y
-15.7%
ABL Bio
Market Cap: ₩4.9t
A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
A298380
₩86,800.00
7D
4.2%
1Y
-0.7%
ALTEOGEN
Market Cap: ₩22.1t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩317,500.00
7D
8.2%
1Y
-5.5%
Caregen
Market Cap: ₩3.1t
A biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide.
A214370
₩64,000.00
7D
-4.2%
1Y
30.5%
ST PharmLtd
Market Cap: ₩2.2t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩107,600.00
7D
6.2%
1Y
15.9%
Aimed Bio
Market Cap: ₩1.7t
Develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases.
A0009K0
₩27,050.00
7D
9.5%
1Y
n/a
Kolon TissueGene
Market Cap: ₩2.2t
Develops cell therapies for orthopedic diseases and other unmet medical needs.
A950160
₩25,600.00
7D
45.7%
1Y
-34.8%
Sam Chun Dang Pharm
Market Cap: ₩4.4t
Engages in the manufacturing and sale of pharmaceutical products in South Korea.
A000250
₩189,800.00
7D
15.0%
1Y
2.5%
Celltrion
Market Cap: ₩46.3t
A biopharmaceutical company, engages in the development, production, and sale of development, production, and sale of medicinal products.
A068270
₩202,000.00
7D
3.6%
1Y
21.2%
JS Link
Market Cap: ₩1.4t
A genome-based biotechnology company, focuses on the research and development of genome analysis services in South Korea and internationally.
A127120
₩41,500.00
7D
3.5%
1Y
144.7%
LigaChem Biosciences
Market Cap: ₩4.2t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩114,400.00
7D
3.2%
1Y
-26.8%
OliX Pharmaceuticals
Market Cap: ₩2.4t
A clinical stage pharmaceutical company, focuses on developing RNA interference (RNAi) therapeutics for dermal, ophthalmic, and pulmonary diseases.
A226950
₩112,500.00
7D
-8.9%
1Y
95.0%
Orum Therapeutics
Market Cap: ₩1.5t
A biopharmaceutical company, engages in the research and development of pharmaceuticals for cancer and immune diseases in South Korea and the United States.
A475830
₩66,900.00
7D
14.4%
1Y
163.9%
Voronoi
Market Cap: ₩3.3t
Researches, develops, and discovers small molecule kinase inhibitors in South Korea.
A310210
₩180,700.00
7D
14.7%
1Y
47.3%